PAVmed Inc. (PAVM): Capital Expenditures

Annual figures by period end, from SEC filings.

$31.0K
Year ended 2025-12-31
$52.0K
Trailing 12 months to 2026-06-30
-72.8%
3-year compound annual growth
-10.8%
5-year compound annual growth
$1.54M2016-12-31: $21.8K2017-12-31: $5.3K2018-12-31: $26.6K2019-12-31: $27.0K2020-12-31: $55.0K2021-12-31: $1.47M2022-12-31: $1.54M2023-12-31: $242.0K2024-12-31: $55.0K2025-12-31: $31.0K$31.0K
2016-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$31.0K-43.6%2026-03-27, From 2025-01-01
2024-12-31$55.0K-77.3%2026-03-27, From 2024-01-01
2023-12-31$242.0K-84.3%2025-03-24, From 2023-01-01
2022-12-31$1.54M+4.8%2024-03-25, From 2022-01-01
2021-12-31$1.47Mn/m2023-03-14, From 2021-01-01
2020-12-31$55.0K+103.7%2022-04-06, From 2020-01-01
2019-12-31$27.0K+1.5%2021-03-15, From 2019-01-01
2018-12-31$26.6K+402.0%2020-04-14, From 2018-01-01
2017-12-31$5.3K-75.7%2019-04-01, From 2017-01-01
2016-12-31$21.8Kn/a2018-03-14, From 2016-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
PAVmed Inc. (PAVM)2025-12-31$31.0K-43.6%
SANUWAVE Health, Inc. (SNWV)2025-12-31$1.94M+296.3%
Lucid Diagnostics Inc. (LUCD)2025-12-31$197.0K-33.4%
Premier Air Charter Holdings Inc. (PREM)2025-12-31$2.55M+70.8%
Beyond Air, Inc. (XAIR)2026-03-31$1.02M-82.6%
TriSalus Life Sciences, Inc. (TLSI)2025-12-31$918.0K+166.1%
Adagio Medical Holdings, Inc. (ADGM)2025-12-31$374.0Kn/a
Cytosorbents Corp (CTSO)2025-12-31$164.0K-42.3%
Interpace Biosciences, Inc. (IDXG)2025-12-31$356.0K-59.4%

Compare PAVM, SNWV, LUCD, PREM side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗